Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Issue : The Pharmaceutical Journal, September 2009

Sort by: Newest first Oldest first A-Z Z-A

  • Frenchay hospital sign

    Fatal overdose after prescribing error was manslaughter

    30 SEP 2009 15:55

    A jury has ruled that the death of a woman caused by an overdose of idarubicin after she was prescribed four times the amount she needed was manslaughter by gross neglect, returning a verdict of unlawful killing.

  • Society closes investigation into Manchester MPharm

    30 SEP 2009 15:29

    The Royal Pharmaceutical Society has announced that it will take no further action over allegations of marking irregularities on the University of Manchester’s master of pharmacy undergraduate degree course.

  • Gabapentin plus nortriptyline cuts neuropathic pain

    30 SEP 2009 15:27

    Neuropathic pain is relieved more effectively by combination treatment with the anticonvulsant gabapentin and the antidepressant nortriptyline than by treatment with either drug alone, a study published online in The Lancet has shown.

  • The Royal Pharmaceutical Society of Great Britain

    Society restructure sees loss of director and several department head positions Subscription

    29 SEP 2009 15:14

    Organisational changes at the Royal Pharmaceutical Society — including the loss of 21 posts — to establish the staffing structure for the new professional body will come into effect on 1 October 2009.

  • Drug alert: Cervarix HPV vaccine Subscription

    29 SEP 2009 15:10

    All stocks of Cervarix human papilloma virus (HPV) vaccine batch number AHPVA043BB should be quarantined, following the death of a 14-year-old girl in Coventry.

  • Everolimus launched as advanced kidney cancer treatment Subscription

    29 SEP 2009 14:04

    Everolimus (Afinitor), a protein kinase inhibitor, is now available in the UK for the treatment of advanced kidney cancer in patients whose disease has progressed despite first-line treatment with vascular endothelial growth factor targeted therapy.

  • Boots logo

    Boots to pay first year’s fees for professional body, as well as for regulator Subscription

    29 SEP 2009 13:57

    Boots UK will pay for all its pharmacists to join the new professional body for pharmacy for the first year of its operation, the company has announced, in a bid to support the creation of the organisation.

  • Local knowledge determines commissioning success Subscription

    29 SEP 2009 13:50

    Good interprofessional relationships and local knowledge of who is who within a primary care trust can determine how successful pharmacists are at being commissioned to deliver services, according to a Government pharmacy adviser.

  • European review confirms risk of jaw osteonecrosis with bisphosphonates Subscription

    29 SEP 2009 13:45

    Treatment with bisphosphonates puts patients at an increased risk of osteonecrosis of the jaw (ONJ) and this should be clearly communicated to healthcare professionals and patients, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has concluded following a review of the risk of ONJ associated with bisphosphonate use.

  • Transplant group issues reminder about substitution risk for ciclosporin Subscription

    28 SEP 2009 14:52

    Pharmacists and other healthcare professionals have been reminded of the risk to transplant patients of ciclosporin substitution, following the launch of a new formulation of the immunosuppressant.

Show  10 per page20 per page50 per page

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.